Stocktoria
Annexon, Inc. ANNX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-24
Annexon, Inc. statistics & valuation
Market cap$897.9M
P / B4.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -74.5% | -39.5% | -45.1% | -49.8% | -45.4% |
| Return on equity | -97.7% | -47.2% | -53.6% | -61.4% | -56.2% |
| Current ratio | 5.68 | 10.37 | 14.72 | 11.10 | 11.39 |
Source: SEC EDGAR filings · CIK 0001528115 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.